Trimetazidine is a pharmaceutical raw material and an active pharmaceutical ingredient (API) used in the manufacturing of finished dosage forms. It is an antianginal metabolic compound belonging to the fatty acid oxidation inhibitor class, which shifts cardiac energy metabolism toward glucose oxidation to improve energy efficiency under ischemic conditions.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 5011-34-7
Trimetazidine dihydrochloride
pharmaceutical raw material
Ent-Atorvastatin
pharmaceutical raw material
Odevixibat
pharmaceutical raw material
Sodium oxybate
pharmaceutical raw material
(alphaR,2R)-alpha-Phenyl-2-piperidineacetamide
pharmaceutical raw material
Trimetazidine-d8 Dihydrochloride
pharmaceutical raw material
1-Nitroso-4-[(2,3,4-trimethoxyphenyl)methyl]piperazine
nitrosamine impurity standard
(4-Benzylpiperazin-2-yl)methanol
research compound
1-[(2,3,4-trimethoxyphenyl)methyl]piperazine
UHWVSEOVJBQKBE-UHFFFAOYSA-N
COC1=C(C(=C(C=C1)CN2CCNCC2)OC)OC